United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded Apr 20, 2026 · Filed Apr 21, 2026

On Apr 20, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$577.86 for US$5.78M under a trading plan, leaving 18,876 shares. Filed Apr 21, 2026 (Form 4).

Sold
10,000 shares
Price
US$577.86 average (US$572.33 to US$585.36)
Value
US$5.78M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 20, 2026Common StockOption exercise10,000US$135.4228,876Direct
Apr 20, 2026Common StockSale880US$572.3327,996Direct
Apr 20, 2026Common StockSale1,543US$573.4526,453Direct
Apr 20, 2026Common StockSale442US$574.0926,011Direct
Apr 20, 2026Common StockSale1,010US$575.4125,001Direct
Apr 20, 2026Common StockSale1,398US$576.3723,603Direct
Apr 20, 2026Common StockSale687US$577.2722,916Direct
Apr 20, 2026Common StockSale500US$578.9022,416Direct
Apr 20, 2026Common StockSale340US$579.8622,076Direct
Apr 20, 2026Common StockSale488US$581.6621,588Direct
Apr 20, 2026Common StockSale983US$582.4720,605Direct
Apr 20, 2026Common StockSale1,009US$583.5519,596Direct
Apr 20, 2026Common StockSale482US$584.4919,114Direct
Apr 20, 2026Common StockSale238US$585.3618,876Direct

Source

View original at SEC

Related